Linked e-resources
Details
Table of Contents
Preface; Acknowledgements; Contents; Editors and Contributors; Abbreviations; List of Figures; List of Tables; Chapter 1 Introduction ; The Bioeconomy as a Biotechnological-Innovation Economy; The Bioeconomy as a Biomass Economy; The Bioeconomy as a Novel Form of Capitalism; Value in the Bioeconomy; Life Itself; Labor; Speculation; Enclosure and Assets; Subjectivities and the Bioeconomy; References; Part I Promissory and Performative: Remaking Institutions for the Bioeconomy; Chapter 2 The "Entrepreneurial State" and the Leveraging of Life in the Field of Regenerative Medicine
Introduction: The Entrepreneurial State and Translational MedicineMethods; Regenerative Medicine and the Leveraging of Life; The Commercialisation Imperative: The Cell and Gene Therapy Catapult; The Promotion of Interdisciplinarity; Reconfiguring Governance Mechanisms: Accelerating Access to Regenerative Medicines; Reframing the Healthcare System as an Innovation Asset; Discussion and Conclusions; References; Chapter 3 Technologies of Governance: Science, State and Citizen in Visions of the Bioeconomy ; Introduction; Theorizing the Bioeconomy; Potential and Urgency; Building a Better Fish
Ordering InstitutionsFailing the Future; Spawning the Bioeconomy; Governing Future Consumers; Conclusion; References; Chapter 4 "Having a Structuring Effect on Europe": The Innovative Medicines Initiative and the Construction of the European Health Bioeconomy ; Introduction; Analytic Perspective and Methodology; Discursive Genealogies of European Construction; From the Lisbon Agenda to the Health Bioeconomy; The Origins of IMI in the European Technology Platforms (ETPs) and Joint Technology Initiatives (JTIs); The "Strategic Research Agenda" and the Translational Goals of IMI
Enacting the Public-Private Partnership: "Changing the Way We Do Research in Europe"The Leading Role of the Pharmaceutical Industry; Criticisms, Challenges and Rhetorical Strategies of Legitimacy: "When You Dine with the Devil, You'd Better Have Long Forks"; Conclusions; References; Part II Making Value and Remaking Research in the Bioeconomies; Chapter 5 The Underworlds Project and the "Collective Microbiome": Mining Biovalue from Sewage ; Introduction; Shit and Sewage; Flushing Data; Everybody Poops; Microbes as (Not) Humans; Conclusion: The Collective Microbiome and Bioeconomic Proxies
Introduction: The Entrepreneurial State and Translational MedicineMethods; Regenerative Medicine and the Leveraging of Life; The Commercialisation Imperative: The Cell and Gene Therapy Catapult; The Promotion of Interdisciplinarity; Reconfiguring Governance Mechanisms: Accelerating Access to Regenerative Medicines; Reframing the Healthcare System as an Innovation Asset; Discussion and Conclusions; References; Chapter 3 Technologies of Governance: Science, State and Citizen in Visions of the Bioeconomy ; Introduction; Theorizing the Bioeconomy; Potential and Urgency; Building a Better Fish
Ordering InstitutionsFailing the Future; Spawning the Bioeconomy; Governing Future Consumers; Conclusion; References; Chapter 4 "Having a Structuring Effect on Europe": The Innovative Medicines Initiative and the Construction of the European Health Bioeconomy ; Introduction; Analytic Perspective and Methodology; Discursive Genealogies of European Construction; From the Lisbon Agenda to the Health Bioeconomy; The Origins of IMI in the European Technology Platforms (ETPs) and Joint Technology Initiatives (JTIs); The "Strategic Research Agenda" and the Translational Goals of IMI
Enacting the Public-Private Partnership: "Changing the Way We Do Research in Europe"The Leading Role of the Pharmaceutical Industry; Criticisms, Challenges and Rhetorical Strategies of Legitimacy: "When You Dine with the Devil, You'd Better Have Long Forks"; Conclusions; References; Part II Making Value and Remaking Research in the Bioeconomies; Chapter 5 The Underworlds Project and the "Collective Microbiome": Mining Biovalue from Sewage ; Introduction; Shit and Sewage; Flushing Data; Everybody Poops; Microbes as (Not) Humans; Conclusion: The Collective Microbiome and Bioeconomic Proxies